July 05, 2009 06:00 PM Eastern Time

BUSINESS WIRE

Alcon Commences Phase 2 Clinical Trial of NovaBay’s NVC-422 for Viral Conjunctivitis

Opens in new window

Download

Thumbnail JPEG, 72x14, 15.7 KB
Preview JPEG, 144x27, 18.0 KB
Small JPEG, 300x57, 24.8 KB
Full Size JPEG, 1379x260, 67.7 KB

Smart Multimedia Gallery

http://www.businesswire.com/multimedia/home/20090705005009/en/1821156/Alcon-Commences-Phase-2-Clinical-Trial-NovaBay%E2%80%99s

View and Share Logo

Share

Email

All News | News with Multimedia > News Release: Alcon Commences Phase 2 Clinical Trial of NovaB...